{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:42:59Z","timestamp":1648514579561},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.2515\/therapie:2004053","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T07:30:31Z","timestamp":1174030231000},"page":"270-271","source":"Crossref","is-referenced-by-count":0,"title":["Pemphigo\u00efde bulleuse sous Biostim\u00ae (Glycoprot\u00e9ine extraite de Klebsiella pneumoniae)"],"prefix":"10.1016","volume":"59","author":[{"given":"Guillaume","family":"Chaby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Dascotte-Barbeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Viseux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Andr\u00e9jak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Denoeux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2004053_bb1900","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie:2004053_bb1905","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archderm.1976.01630250039012","article-title":"Occurrence of bullous pemphigoid after furosemide therapy","volume":"112","author":"Fellner","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie:2004053_bb1910","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2230.1990.tb02020.x","article-title":"Bullous pemphigoid: an adverse effect of ampicillin","volume":"15","author":"Hodak","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.2515\/therapie:2004053_bb1915","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0560.1989.tb00031.x","article-title":"Penicillamine-induced bullous pemphigoid with pemphigus-like antibodies","volume":"16","author":"Rasmussen","year":"1989","journal-title":"J Cutan Pathol"},{"key":"10.2515\/therapie:2004053_bb1920","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/106002808902300115","article-title":"Bullous pemphigoid associated with captopril [case report]","volume":"23","author":"Mallet","year":"1989","journal-title":"DICP"},{"key":"10.2515\/therapie:2004053_bb1925","first-page":"700","article-title":"Spironolactone-induced pemphigoid","volume":"124","author":"Grange","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.2515\/therapie:2004053_bb1930","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2230.1999.00474.x","article-title":"Bullous pemphigoid developing during systemic therapy with chloroquine","volume":"24","author":"Millard","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.2515\/therapie:2004053_bb1935","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid","volume":"132","author":"Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie:2004053_bb1940","first-page":"111","article-title":"Imputabilit\u00e9 des effets inattendus ou toxiques des m\u00e9dicaments","volume":"40","author":"B\u00e9gaud","year":"1985","journal-title":"Therapie"},{"key":"10.2515\/therapie:2004053_bb1945","series-title":"Monographie Vidal","year":"2003"},{"issue":"Suppl. 1","key":"10.2515\/therapie:2004053_bb1950","first-page":"27","article-title":"Immunostimulating agents: adverse drug reactions: result of a French national inquiry of pharmacovigilance [abstract]","volume":"15","author":"Guy","year":"2001","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716301986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716301986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T06:43:51Z","timestamp":1554273831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716301986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0040595716301986"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2004053","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}